Journal
EMBO JOURNAL
Volume 30, Issue 3, Pages 494-509Publisher
WILEY
DOI: 10.1038/emboj.2010.342
Keywords
erythroid cells; ETS1; RUNX1; SCL/TAL1; T-cell acute lymphoblastic leukaemia (T-ALL)
Categories
Funding
- CIHR [MOP-82813]
- NIH NIAMS [R01AR045113]
- Ontario Research Fund Computational Regulomics Training Postdoctoral Fellowship
Ask authors/readers for more resources
TAL1/SCL is a master regulator of haematopoiesis whose expression promotes opposite outcomes depending on the cell type: differentiation in the erythroid lineage or oncogenesis in the T-cell lineage. Here, we used a combination of ChIP sequencing and gene expression profiling to compare the function of TAL1 in normal erythroid and leukaemic T cells. Analysis of the genome-wide binding properties of TAL1 in these two haematopoietic lineages revealed new insight into the mechanism by which transcription factors select their binding sites in alternate lineages. Our study shows limited overlap in the TAL1-binding profile between the two cell types with an unexpected preference for ETS and RUNX motifs adjacent to E-boxes in the T-cell lineage. Furthermore, we show that TAL1 interacts with RUNX1 and ETS1, and that these transcription factors are critically required for TAL1 binding to genes that modulate T-cell differentiation. Thus, our findings highlight a critical role of the cellular environment in modulating transcription factor binding, and provide insight into the mechanism by which TAL1 inhibits differentiation leading to oncogenesis in the T-cell lineage. The EMBO Journal (2011) 30, 494-509. doi:10.1038/emboj.2010.342; Published online 21 December 2010
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available